Cross Country Healthcare Inc (CCRN)
10.34
-0.04
(-0.39%)
USD |
NASDAQ |
Nov 22, 16:00
10.36
+0.02
(+0.15%)
After-Hours: 20:00
Cross Country Healthcare Revenue (Quarterly): 315.12M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 315.12M |
| June 30, 2024 | 339.77M |
| March 31, 2024 | 379.17M |
| December 31, 2023 | 414.04M |
| September 30, 2023 | 442.29M |
| June 30, 2023 | 540.70M |
| March 31, 2023 | 622.71M |
| December 31, 2022 | 628.22M |
| September 30, 2022 | 636.10M |
| June 30, 2022 | 753.56M |
| March 31, 2022 | 788.73M |
| December 31, 2021 | 640.68M |
| September 30, 2021 | 374.90M |
| June 30, 2021 | 331.83M |
| March 31, 2021 | 329.24M |
| December 31, 2020 | 215.61M |
| September 30, 2020 | 193.97M |
| June 30, 2020 | 216.78M |
| March 31, 2020 | 210.06M |
| December 31, 2019 | 215.10M |
| September 30, 2019 | 209.20M |
| June 30, 2019 | 202.76M |
| March 31, 2019 | 195.17M |
| December 31, 2018 | 200.91M |
| September 30, 2018 | 200.72M |
| Date | Value |
|---|---|
| June 30, 2018 | 204.57M |
| March 31, 2018 | 210.29M |
| December 31, 2017 | 219.67M |
| September 30, 2017 | 228.49M |
| June 30, 2017 | 209.31M |
| March 31, 2017 | 207.57M |
| December 31, 2016 | 222.52M |
| September 30, 2016 | 214.99M |
| June 30, 2016 | 199.44M |
| March 31, 2016 | 196.58M |
| December 31, 2015 | 193.15M |
| September 30, 2015 | 195.69M |
| June 30, 2015 | 192.62M |
| March 31, 2015 | 185.96M |
| December 31, 2014 | 188.13M |
| September 30, 2014 | 188.94M |
| June 30, 2014 | 122.66M |
| March 31, 2014 | 118.09M |
| December 31, 2013 | 109.18M |
| September 30, 2013 | 108.05M |
| June 30, 2013 | 110.77M |
| March 31, 2013 | 110.32M |
| December 31, 2012 | 111.73M |
| September 30, 2012 | 112.26M |
| June 30, 2012 | 108.85M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
193.97M
Minimum
Sep 2020
788.73M
Maximum
Mar 2022
429.43M
Average
377.04M
Median
Revenue (Quarterly) Benchmarks
| Ensign Group Inc | 1.082B |
| TransMedics Group Inc | 108.76M |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.035M |
| IGC Pharma Inc | 0.412M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.555M |
| Total Expenses (Quarterly) | 309.76M |
| EPS Diluted (Quarterly) | 0.08 |
| Enterprise Value | 276.34M |
| Gross Profit Margin (Quarterly) | 20.36% |
| Profit Margin (Quarterly) | 0.81% |
| Earnings Yield | -0.48% |
| Operating Earnings Yield | 11.08% |
| Normalized Earnings Yield | 8.216 |